Zack Lynch

Insider Reports History

Location
Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Zack Lynch:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. Director Class A Common Stock 9,681,673 03 Dec 2021 by JAZZ Human Performance Technology Fund, L.P.
Pear Therapeutics, Inc. Director Class A Common Stock 1,084,914 03 Dec 2021 by JAZZ Human Performance Opportunity Fund, L.P.
Pear Therapeutics, Inc. Director Stock Option (Right to Buy) 29,448 03 Dec 2021 Direct

Insider Reports Filed by Zack Lynch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000106299321012390-lynch-zack-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 4 +$100,000 4 Director 07 Dec 2021, 16:23
/report/000106299321012364-lynch-zack-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 0 $0 3 Director 07 Dec 2021, 16:08